Radiation Oncology

Article	Citations
Outcome of patients with soft tissue sarcomas of the extremities and trunk treated by (neo)adjuvant intensity modulated radiation therapy with curative intent	60
Treatment outcomes and radiotherapy deintensification strategies in human papillomavirus-associated tonsil cancer	58
Estimating cancer risks due to whole lungs low dose radiotherapy with different techniques for treating COVID-19 pneumonia	55
A multifunctional targeted nano-delivery system with radiosensitization and immune activation in glioblastoma	52
Pamiparib as consolidation treatment after concurrent chemoradiotherapy of limited-stage small cell lung cancer: a single-arm, open-label phase 2 trial	51
Dosimetric comparison of two dose expansion methods in intensity modulated radiotherapy for breast cancer	48
A retrospective study comparing definitive chemoradiotherapy vs. chemoradiotherapy followed by surgery in T4 esophageal squamous cell carcinoma patients who were downstaged after neochemoradiotherapy	45
Using meta-analysis and CNN-NLP to review and classify the medical literature for normal tissue complication probability in head and neck cancer	41
Extensive clinical target volume in postoperative chemoradiotherapy for esophageal squamous cell carcinoma: a phase II clinical trial (ESO-Shanghai 9)	41
CircRNA_101491 regulated the radiation sensitivity of esophageal squamous cell carcinomas via sponging miR-125a-5p	41
Compliance of volunteers in a fully-enclosed patient rotation system for MR-guided radiation therapy: a prospective study	40
Correction to: 125I seeds irradiation inhibits tumor growth and induces apoptosis by Ki-67, P21, survivin, livin and caspase-9 expression in lung carcinoma xenografts	37
The impact of pelvic radiotherapy on the gut microbiome and its role in radiation-induced diarrhoea: a systematic review	37
Efficacy and safety of tyrosine kinase inhibitors with thoracic radiotherapy for patients with oncogene-mutated non-small cell lung cancer: a meta-analysis	36
Neoadjuvant chemoradiotherapy in patients with unresectable locally advanced sigmoid colon cancer: clinical feasibility and outcome	35
Correction to: Adjuvant hysterectomy following primary chemoradiation for stage IB2 and IIA2 cervical cancer: a retrospective comparison of complications for open versus minimally invasive surgery	34
Preoperative short-course radiotherapy followed by consolidation chemotherapy for treatment with locally advanced rectal cancer: a meta-analysis	33
Evaluating differences in respiratory motion estimates during radiotherapy: a single planning 4DMRI versus daily 4DMRI	32
125I seed brachytherapy for non-central pelvic recurrence of cervical cancer after external beam radiotherapy	32
Whole lung radiomic features are associated with overall survival in patients with locally advanced non-small cell lung cancer treated with definitive radiotherapy	32
Current status and perspectives of interventional clinical trials for brain metastases: analysis of ClinicalTrials.gov	32
Direct comparison of low-dose-rate brachytherapy versus radical prostatectomy using the surgical definition of biochemical recurrence for patients with intermediate-risk prostate cancer	30
Injection of hydrogel spacer increased maximal intrafractional prostate motion in anterior and superior directions during volumetric modulated arc therapy-stereotactic body radiation therapy for prost	30
Knowledge-based DVH estimation and optimization for breast VMAT plans with and without avoidance sectors	28
Radiotherapy refusal in breast cancer with breast-conserving surgery	28

Ventilation and perfusion MRI at a 0.35 T MR-Linac: feasibility and reproducibility study	28
The role of neoadjuvant radiochemotherapy in the management of localized high-grade soft tissue sarcoma	27
Comparison of deep learning networks for fully automated head and neck tumor delineation on multi-centric PET/CT images	26
A survey of cancer patients’ interest in undertaking exercise to promote relaxation during radiotherapy for breast cancer and metastatic cancer	25
Clinical features and risk factors for interstitial lung disease spreading in low-dose irradiated areas after definitive radiotherapy with or without durvalumab consolidation therapy for patients with	25
Hypofractionated versus standard fractionation radiotherapy for merkel cell carcinoma	24
Efficacy of concurrent chemoradiotherapy alone for loco-regionally advanced nasopharyngeal carcinoma: long-term follow-up analysis	24
Dosimetric parameters and absolute monocyte count can predict the prognosis of acute hematologic toxicity in cervical cancer patients undergoing concurrent chemotherapy and volumetric-modulated arc th	24
Review of cone beam computed tomography based online adaptive radiotherapy: current trend and future direction	23
Impact of radiation response on survival in pediatric medulloblastoma with residual or disseminated disease	23
Real world clinical experience using daily intelligence-assisted online adaptive radiotherapy for head and neck cancer	23
Pathological and genomic phenotype of second neuroendocrine carcinoma during long-term follow-up after radical radiotherapy for nasopharyngeal carcinoma	22
Selectively recommend 18F-FDG PET/CT for patients with de novo nasopharyngeal carcinoma in endemic areas	22
Simulation CT-based radiomics for prediction of response after neoadjuvant chemo-radiotherapy in patients with locally advanced rectal cancer	22
Protective ileostomy increased the incidence of rectal stenosis after anterior resection for rectal cancer	21
Cardiac-sparing radiotherapy for locally advanced non-small cell lung cancer	21
Establishment of prognostic models for adenocarcinoma of oesophagogastric junction patients with neoadjuvant chemoradiotherapy: a real-world study	21
Biological target volume based on fluorine-18-fluorode-oxyglucose positron emission tomography/computed tomography imaging: a spurious proposition?	21
Risk of temporal lobe necrosis between proton beam and volumetric modulated arc therapies in patients with different head and neck cancers	20
Correction to: High dose simultaneous integrated boost for node positive cervical cancer	20
Preliminary study of feasibility of surface-guided radiotherapy with concurrent tumor treating fields for glioblastoma: region of interest	20
Linear accelerator-based stereotactic radiotherapy for brain metastases, including multiple and large lesions, carries a low incidence of acute toxicities: a retrospective analysis	20
Dosimetric evaluation of photons versus protons in postmastectomy planning for ultrahypofractionated breast radiotherapy	20
Correction: Artificial intelligence contouring in radiotherapy for organs-at-risk and lymph node areas	20
Characteristics of locoregional extension of unilateral nasopharyngeal carcinoma and suggestions for clinical target volume delineation	20
The roles of CC chemokines in response to radiation	19
The safety of an MRI simulation-guided boost after short-course preoperative radiotherapy for unresectable rectal cancer (SUNRISE): interim analysis of a randomized phase II trial	19
Effects of whole-brain radiation therapy on the blood–brain barrier in immunocompetent and immunocompromised mouse models	19
Assessing intra- and interfraction motion and its dosimetric impacts on cervical cancer adaptive radiotherapy based on 1.5T MR-Linac	19
Prospective phase II trial of preoperative hypofractionated proton therapy for extremity and truncal soft tissue sarcoma: the PRONTO study rationale and design	19
A deep learning-informed interpretation of why and when dose metrics outside the PTV can affect the risk of distant metastasis in SBRT NSCLC patients	18
Timing matters: diurnal spine length variation in pediatric patients during radiotherapy	18
Predictors of osteoradionecrosis following irradiated tooth extraction	18
Dose-escalated radiotherapy to 82 Gy for prostate cancer following insertion of a peri-rectal hydrogel spacer: 3-year outcomes from a phase II trial	18
Stereotactic body radiation therapy for the treatment of localized prostate cancer in men with underlying inflammatory bowel disease	18
Early recovery of leukocyte subsets is associated with favorable progression-free survival in patients with inoperable stage II/III NSCLC after multimodal treatment: a prospective explorative study	17
Radiation therapy for retroperitoneal sarcoma: practice patterns in North America	17
Dosimetric effect of respiratory motion on planned dose in whole-breast volumetric modulated arc therapy using moderate and ultra-hypofractionation	17
Outcomes of definitive radiotherapy vs. laryngectomy followed by adjuvant radiotherapy in patients with locally advanced laryngeal squamous cell carcinoma: real-world experience in a referral cancer c	17
Comparison of the distribution of lymph node metastases compared to healthy lymph nodes in breast cancer	16
Prostate radiotherapy may cause fertility issues: a retrospective analysis of testicular dose following modern radiotherapy techniques	16
Clinical practice in stereotactic radiotherapy delivery at treatment unit: a practitioner survey and consensus-based recommendations for multidisciplinary professional development	16
Personalising treatment plan quality review with knowledge-based planning in the TROG 15.03 trial for stereotactic ablative body radiotherapy in primary kidney cancer	16
Deformable registration for nasopharyngeal carcinoma using adaptive mask and weight allocation strategy based CycleFCNs model	16
Evaluating the impact of possible interobserver variability in CBCT-based soft-tissue matching using TCP/NTCP models for prostate cancer radiotherapy	15
Radio-opaque contrast agents for liver cancer targeting with KIM during radiation therapy (ROCK-RT): an observational feasibility study	15
Functional outcome after Brachytherapy with bi-nuclide (Ru-106/Iodine-125) plaques in large uveal melanomas	15
Ganetespib selectively sensitizes cancer cells for proximal and distal spread-out Bragg peak proton irradiation	15
Radiotherapy with S-1 for the treatment of esophageal squamous cell carcinoma 75 years or older	15
Influence and optimization strategy of the magnetic field in 1.5 T MR-linac liver stereotactic radiotherapy	15

High buttocks supine position to reduce small bowel exposure in gynecological radiotherapy	15
Treatment plan comparison for irradiation of multiple brain metastases with hippocampal avoidance whole brain radiotherapy and simultaneous integrated boost using the Varian Halcyon and the Elekta Syn	14
Prognostic value of baseline 18F-FDG PET/CT in patients with esophageal squamous cell carcinoma treated with definitive (chemo)radiotherapy	14
Use of focal radiotherapy boost for prostate cancer: radiation oncologists’ perspectives and perceived barriers to implementation	14
Impact of high dose radiotherapy for breast tumor in locoregionally uncontrolled stage IV breast cancer: a need for a risk-stratified approach	14
Effects of EGFR-TKIs combined with intracranial radiotherapy in EGFR-mutant non-small cell lung cancer patients with brain metastases: a retrospective multi-institutional analysis	14
Intrafraction organ movement in adaptive MR-guided radiotherapy of abdominal lesions – dosimetric impact and how to detect its extent in advance	14
The role of the soft palate dose regarding normal tissue toxicities in older adults with head and neck cancer undergoing definitive radiotherapy	14
Efficacy and safety of induction immunochemotherapy followed by radiotherapy for patients with unresectable locally advanced non-small cell lung cancer: A retrospective study	13
Impact of chronic graft-versus-host disease on quality of life and cognitive function of long-term transplant survivors after allogeneic hematopoietic stem cell transplantation with total body irradia	13
Evaluation of PTV margins with daily iterative online adaptive radiotherapy for postoperative treatment of endometrial and cervical cancer: a prospective single-arm phase 2 study	13
Generation of tissues outside the field of view (FOV) of radiation therapy simulation imaging based on machine learning and patient body outline (PBO)	13
The MRI-guided two adaptive brachytherapy fractions versus one adaptive brachytherapy fraction in one application for the cervical cancer: a retrospective study	13
Proton therapy with a fixed beamline for skull-base chordomas and chondrosarcomas: outcomes and toxicity	13
Dose prediction for cervical cancer VMAT patients with a full-scale 3D-cGAN-based model and the comparison of different input data on the prediction results	13
Chemoradiation for oesophageal cancer: the choice of treatment modality	13
Dosimetric evaluation of VMAT and helical tomotherapy techniques comparing conventional volumes with clinical target volumes based on new ESTRO ACROP post-mastectomy with immediate implant reconstruct	13
Clinical outcomes and lung toxicities after lung SABR using dynamic conformal arc therapy: a single-institution cohort study	13
The role of 18F-FDG PET/MRI in assessing pathological complete response to neoadjuvant chemotherapy in patients with breast cancer: a systematic review and meta-analysis	13
Automatic IMRT treatment planning through fluence prediction and plan fine-tuning for nasopharyngeal carcinoma	13
Multi-institutional evaluation of a Pareto navigation guided automated radiotherapy planning solution for prostate cancer	13
A PET/CT radiomics model for predicting distant metastasis in early-stage non–small cell lung cancer patients treated with stereotactic body radiotherapy: a multicentric study	13
Application of four-dimensional cone beam computed tomography in lung cancer radiotherapy	12
Hypofractionated radiation leads to more rapid bleeding cessation in women with vaginal bleeding secondary to gynecologic malignancy	12
High-dose stereotactic radiotherapy boost in the treatment of squamous cell carcinoma of the head and neck region	12
Dosimetric evaluation of LINAC-based single-isocenter multi-target multi-fraction stereotactic radiosurgery with more than 20 targets: comparing MME, HyperArc, and RapidArc	12
Boost modalities in cervical cancer: dosimetric comparison between intracavitary BT vs. intracavitary + interstitial BT vs. SBRT.	12
Deep learning tools for the cancer clinic: an open-source framework with head and neck contour validation	12
Pneumonitis after normofractionated radioimmunotherapy: a method for dosimetric evaluation	12
Identification of variables and development of a prediction model for DIBH eligibility in left-sided breast cancer radiotherapy: a prospective cohort study with temporal validation	12
Localized fine-tuning and clinical evaluation of deep-learning based auto-segmentation (DLAS) model for clinical target volume (CTV) and organs-at-risk (OAR) in rectal cancer radiotherapy	12
Simultaneous integrated boost (SIB) to dominant intra-prostatic lesions during extreme hypofractionation for prostate cancer: the impact of rectal spacers	12
Risk of developing second malignant neoplasms in patients with neuroblastoma: a population study of the US SEER database	11
Influence of target dose heterogeneity on dose sparing of normal tissue in peripheral lung tumor stereotactic body radiation therapy	11
Interfractional variation in whole-breast VMAT irradiation: a dosimetric study with complementary SGRT and CBCT patient setup	11
Therapeutic and prognostic impact of target volume delineation in postoperative radiotherapy for high-grade glioma patients with subventricular zone involvement	11
Research trends and hot spots in the prevention and management of radiation dermatitis: a bibliometric analysis based on CiteSpace	11
CT radiomics-based long-term survival prediction for locally advanced non-small cell lung cancer patients treated with concurrent chemoradiotherapy using features from tumor and tumor organismal envir	11
Generation of ozone during irradiation using medical linear accelerators: an experimental study	11
Radiologic criteria of retropharyngeal lymph node metastasis in maxillary sinus cancer	11
A novel knowledge-based prediction model for estimating an initial equivalent uniform dose in semi-auto-planning for cervical cancer	10
Focal HDR brachytherapy boost to stereotactic radiotherapy (fBTsRT) for prostate cancer: a phase II randomized controlled trial	10
MR-guided SBRT boost for patients with locally advanced or recurrent gynecological cancers ineligible for brachytherapy: feasibility and early clinical experience	10
Correction: Real world clinical experience using daily intelligence-assisted online adaptive radiotherapy for head and neck cancer	10
Radiobiological and dosimetric comparison of 60Co versus 192Ir high-dose-rate intracavitary-interstitial brachytherapy for cervical cancer	10
Cardiac substructure dose distributions in node-positive and node-negative breast cancer patients undergoing 3D-CRT: comparing the predictive accuracy of mean heart dose and mean left ventricular dose	10
Dummy run quality assurance study in the Korean Radiation Oncology Group 19 − 09 multi-institutional prospective cohort study of breast cancer	10
End of treatment cone-beam computed tomography (CBCT) is predictive of radiation response and overall survival in oropharyngeal squamous cell carcinoma	10
Toxicity of external beam accelerated partial-breast irradiation (APBI) in adjuvant therapy of early-stage breast cancer: prospective randomized study	10
HLA-DQA1 expression is associated with prognosis and predictable with radiomics in breast cancer	10
High-dose thoracic radiation therapy for non-small cell lung cancer: a novel grading scale of radiation-induced lung injury for symptomatic radiation pneumonitis	10
FAPI-PET/CT guided radiotherapy for patients with esophageal cancer	10
Postoperative recurrent patterns of gallbladder cancer: possible implications for adjuvant therapy	10
Comparison of hypofractionation and standard fractionation for post-prostatectomy salvage radiotherapy in patients with persistent PSA: single institution experience	10
Outcomes of metastasis-directed therapy of bone oligometastatic prostate cancer	10
DeepBeam: a machine learning framework for tuning the primary electron beam of the PRIMO Monte Carlo software	10
Single-cell transcriptional analysis of irradiated skin reveals changes in fibroblast subpopulations and variability in caveolin expression	10
Impact of random outliers in auto-segmented targets on radiotherapy treatment plans for glioblastoma	10
Predicting local control of brain metastases after stereotactic radiotherapy with clinical, radiomics and deep learning features	10
Radiation-induced senescence: therapeutic opportunities	10
Lymphocyte recovery from radiation-induced lymphopenia in locally advanced esophageal squamous cell carcinoma: correlations with prognosis and lymphocyte-related organs	10
Paclitaxel and cisplatin combined with concurrent involved-field irradiation in definitive chemoradiotherapy for locally advanced esophageal squamous cell carcinoma: a phase II clinical trial	10
Continuity and coordination of care in highly selected chronic cancer patients treated with multiple repeat radiation therapy	9
Comparison of outcome after stereotactic ablative radiotherapy of patients with metachronous lung versus primary lung cancer	9
BRAF mutation correlates with worse local–regional control following radiation therapy in patients with stage III melanoma	9
Assessing organ at risk position variation and its impact on delivered dose in kidney SABR	9
Development of delayed pulmonary toxicities and transcriptional changes in pre-existing interstitial lung disease mice after partial thoracic irradiation	9
Functional imaging guided stereotactic ablative body radiotherapy (SABR) with focal dose escalation and bladder trigone sparing for intermediate and high-risk prostate cancer: study protocol for phase	9
Comparison of liver exposure in CT-guided high-dose rate (HDR) interstitial brachytherapy versus SBRT in hepatocellular carcinoma	9
The relationship between the radiation dose of pelvic-bone marrow and lymphocytic toxicity in concurrent chemoradiotherapy for cervical cancer	9
Efficacy and safety of particle therapy for inoperable stage II-III non-small cell lung cancer: a systematic review and meta-analysis	9
Pulmonary magnetic resonance-guided online adaptive radiotherapy of locally advanced non-small-cell lung cancer: the PUMA trial	9
High-volume prostate biopsy core involvement is not associated with an increased risk of cancer recurrence following 5-fraction stereotactic body radiation therapy monotherapy	9
Local control and recurrence patterns after stereotactic irradiation delivered in more than 4 fractions for hepatocellular carcinomas and liver metastases: a retrospective study	9
Early-onset adverse events after stereotactic radiosurgery for jugular foramen schwannoma: a mid-term follow-up single-center review of 46 cases	9
Practical recommendations for the management of radiodermatitis: on behalf of the ESTRO RTT committee	9
Prospective superficial EPR in-vivo dosimetry study during hypofractionated radiotherapy of breast cancer patients treated with helical tomotherapy	9
A deep learning-based dose calculation method for volumetric modulated arc therapy	9
Omitting surgery in esophageal cancer patients with complete response after neoadjuvant chemoradiotherapy: a systematic review and meta-analysis	9
Analytical setup margin for spinal stereotactic body radiotherapy based on measured errors	9

Bone matching versus tumor matching in image-guided carbon ion radiotherapy for locally advanced non-small cell lung cancer	9
Retrospective analysis of recurrence patterns and clinical outcome of grade II meningiomas following postoperative radiotherapy	9
Heart atlas for retrospective cardiac dosimetry: a multi-institutional study on interobserver contouring variations and their dosimetric impact	9
Radiotherapy plus anti-PD1 versus radiotherapy for hepatic toxicity in patients with hepatocellular carcinoma	9
Concurrent chemoradiotherapy with S-1 compared with concurrent chemoradiotherapy with docetaxel and cisplatin for locally advanced esophageal squamous cell carcinoma	8
Towards deep-learning (DL) based fully automated target delineation for rectal cancer neoadjuvant radiotherapy using a divide-and-conquer strategy: a study with multicenter blind and randomized valida	8
Stereotactic body radiotherapy in combination with non-frontline PD-1 inhibitors and targeted agents in metastatic renal cell carcinoma	8
PLK4 as a potential target to enhance radiosensitivity in triple-negative breast cancer	8
Evaluating ECM stiffness and liver cancer radiation response via shear-wave elasticity in 3D culture models	8
A nomogram model based on pre-treatment and post-treatment MR imaging radiomics signatures: application to predict progression-free survival for nasopharyngeal carcinoma	8
Palliative radiotherapy for painful lymph node metastases	8
Clinical outcomes and patterns of failure of head and neck mucosal melanoma treated with multiple treatment modalities	8
Synthetic CT generation from CBCT and MRI using StarGAN in the Pelvic Region	8
Prognostic implications of tumor volume reduction during radiotherapy in locally advanced cervical cancer: a risk-stratified analysis	8
A review of diffusion-weighted magnetic resonance imaging in head and neck cancer patients for treatment evaluation and prediction of radiation-induced xerostomia	8
Radiation pneumonitis in patients with non-small-cell lung cancer receiving chemoradiotherapy and an immune checkpoint inhibitor: a retrospective study	8
Dosimetric impact of deep learning-based CT auto-segmentation on radiation therapy treatment planning for prostate cancer	8
Dosimetric benefits of adaptive radiation therapy for patients with stage III non-small cell lung cancer	8
Developing an automatic treatment record review system for quality assurance of patient treatment delivery in radiation therapy	8
Influence of brain metastases on the classification, treatment, and outcome of patients with extracranial oligometastasis: a single-center cross-sectional analysis	8
Prognostic value of tumor measurement parameters and SCC-Ag changes in patients with locally-advanced cervical cancer	8
Gastrointestinal and genitourinary toxicity profiles of metformin versus placebo in men with prostate cancer receiving prostate radiotherapy: interim toxicity results of a double-blinded, multicenter,	8
Comparison of sliding window and field-in-field techniques for tangential whole breast irradiation using the Halcyon and Synergy Agility systems	8
Measuring out-of-field dose to the hippocampus in common radiotherapy indications	8
Salvage re-irradiation using stereotactic body radiation therapy for locally recurrent prostate cancer: the impact of castration sensitivity on treatment outcomes	8
Palliative radiotherapy for tumor bleeding in patients with unresectable pancreatic cancer: a single-center retrospective study	8
Quantification of biological range uncertainties in patients treated at the Krakow proton therapy centre	8
Comparing biological effectiveness guided plan optimization strategies for cranial proton therapy: potential and challenges	8
Outcomes of carbon ion radiotherapy compared with segmentectomy for ground glass opacity-dominant early-stage lung cancer	8
Photobiomodulation as a treatment for dermatitis caused by chemoradiotherapy for squamous cell anal carcinoma: case report and literature review	8
Correction: Evolution of radiation-induced temporal lobe injury after intensity-modulated radiation therapy in nasopharyngeal carcinoma: a large cohort retrospective study	8
Clinical application of MR-Linac in tumor radiotherapy: a systematic review	8
Advancements of radiotherapy for recurrent head and neck cancer in modern era	8
Outcomes of proton therapy for non-small cell lung cancer in patients with interstitial pneumonia	8
Regularity and correlation analysis of regional lymph node metastasis in nonoperative patients with non-small cell lung cancer based on positron emission tomography/computed tomography images	8
Gastric side effects and the stomach dosimetric analysis in left-sided breast cancer radiotherapy in free-breathing and deep inspiration breath-hold technique	8
ALA-RDT in GBM: protocol of the phase I/II dose escalation trial of radiodynamic therapy with 5-Aminolevulinic acid in patients with recurrent glioblastoma	8
Predictive value of delta radiomics in xerostomia after chemoradiotherapy in patients with stage III-IV nasopharyngeal carcinoma	8
Prognostic value of neutrophil to lymphocyte ratio and lymphocyte counts before durvalumab consolidation after radio-chemotherapy in locally advanced non-small cell lung cancer	8
Treatment outcomes of stereotactic body radiation therapy for primary and metastatic sarcoma of the spine	8
Prognostic nomogram for synchronous metastatic nasopharyngeal carcinoma: a retrospective multicentre study	8
Stereotactic MRI-guided radiation therapy for localized prostate cancer (SMILE): a prospective, multicentric phase-II-trial	8
Monte Carlo simulation of linac using PRIMO	8
Applicability of a pathological complete response magnetic resonance-based radiomics model for locally advanced rectal cancer in intercontinental cohort	7
PET/CT standardized uptake value and EGFR expression predicts treatment failure in nasopharyngeal carcinoma	7
Radiotherapy-induced toxicity in prostate cancer patients with hip prostheses	7
Protocol of a phase II study to evaluate the efficacy and safety of deep-inspiration breath-hold daily online adaptive radiotherapy for centrally located lung tumours (PUDDING study)	7
Dosimetry study of three-dimensional print template for 125I implantation therapy	7
Molecular features of glioblastomas in long-term survivors compared to short-term survivors—a matched-pair analysis	7
Treatment results for patients with squamous-cell carcinoma of the anus, a single institution retrospective analysis	7
A novel dosimetric metrics-based risk model to predict local recurrence in nasopharyngeal carcinoma patients treated with intensity-modulated radiation therapy	7
Neurocognitive impact of different irradiation modalities for patients with grade I-II skull base meningioma: a prospective multi-arm cohort study (CANCER COG)	7
Chemoradiotherapy is an alternative choice for patients with primary mediastinal seminoma	7
Minimizing human interference in an online fully automated daily adaptive radiotherapy workflow for bladder cancer	7
A cycle generative adversarial network for improving the quality of four-dimensional cone-beam computed tomography images	7
Apparent diffusion coefficient values predict response to brachytherapy in bulky cervical cancer	7
Preoperative hypofractionated radiotherapy for soft tissue sarcomas: a systematic review	7
Quantifying the reduction of respiratory motion by mechanical ventilation with MRI for radiotherapy	7
A blinded-endpoint, randomized controlled trial of Sanyrene with natural active ingredient for prophylaxis of radiation dermatitis in patients receiving radiotherapy	7
Dosimetric rationale and preliminary experience in proton plus carbon-ion radiotherapy for esophageal carcinoma: a retrospective analysis	7
Cancer care at the time of the fourth industrial revolution: an insight to healthcare professionals’ perspectives on cancer care and artificial intelligence	7
Comparison of data fusion strategies for automated prostate lesion detection using mpMRI correlated with whole mount histology	7
Postoperative radiotherapy for supraglottic cancer on real-world data: can we reduce dose to lymph node levels?	7
Response assessment after stereotactic body radiation therapy for spine and non-spine bone metastases: results from a single institutional study	7
A nomogram based on circulating CD8+ T cell and platelet-to-lymphocyte ratio to predict overall survival of patients with locally advanced nasopharyngeal carcinoma	7
Predicting the survival of patients with painful tumours treated with palliative radiotherapy: a secondary analysis using the 3-variable number-of-risk-factors model	7
Functional brain imaging interventions for radiation therapy planning in patients with glioblastoma: a systematic review	7
Neck muscle training improving the setup of reproducibility in patient with head and neck cancer receiving radiotherapy - a prospective randomized controlled study	7
The investigation of opening modes of head and neck thermoplastic mask for radiotherapy based on finite element analysis	7
Impact of interplay effects on spot scanning proton therapy with motion mitigation techniques for lung cancer: SFUD versus robustly optimized IMPT plans utilizing a four-dimensional dynamic dose simul	7
Definitive irradiation as a first treatment strategy for primary and metastatic sites of newly diagnosed IVB cervical cancer that presented with synchronous oligometastases	7
Simultaneous dose distribution and fluence prediction for nasopharyngeal carcinoma IMRT	7
IMPT of head and neck cancer: unsupervised machine learning treatment planning strategy for reducing radiation dermatitis	7
Radiotherapy outcomes and risk factors for young patients with head-and-neck squamous cell carcinomas: a matched-pair analysis	7
Effectiveness of bladder filling control during online MR-guided adaptive radiotherapy for rectal cancer	7
MOREOVER: multiomics MR-guided radiotherapy optimization in locally advanced rectal cancer	7
Proton therapy and oral mucositis in oral & oropharyngeal cancers: outcomes, dosimetric and NTCP benefit	7
Smoking increases breast toxicity despite adjuvant hypofractionated IMRT in early breast cancer	7
A focused review of statistical practices for relating radiation dose-volume exposure and toxicity	7
Deep learning for segmentation of the cervical cancer gross tumor volume on magnetic resonance imaging for brachytherapy	7
High dose chemoradiotherapy increases chance of organ preservation with satisfactory functional outcome for rectal cancer	7
Mesorectal motion evaluation in rectal cancer MR-guided radiotherapy: an exploratory study to quantify treatment margins	7